The Fusion Investing Portfolio initiated a starting position of 1,000 shares in PFE at $17.68 at 23.40pm AEST.
I will update this post with more details tomorrow. The preferred outcome is for PFE to continue to head lower to allow a sizable position to built at lower prices.
If you’re looking for something good to read try this new post on Seth Klarman at Seeking Alpha

There has been much speculation as to whether Pfizer will cut its dividend. As the speculation has gained momentum it has almost crossed over from speculation to sell newsprint to a fact. When I see this type of investor behaviour I sense an opportunity and try to look at the facts.

PFE is an S&P dividend aristocrat, which means they have increased cash payments for 25 years. My records show PFE has increased their dividend every year since 1980.
Management have maintained the dividend is …

I won’t bore you with a rehash of the numbers, for that you can check the Value Line report.
I’m sure BMW Method practitioners already know PFE is under -2RMS on Mike Klein’s BMW Method 20 year and 25 year charts and only a whisker away on the 16 year chart. The return factor, RF, ranges from 2.54 to 3.25, yummy, and those figures were calculated when PFE was $0.56 higher.
PFE is tantalisingly tasty on every fundamental score. It screams buy me, by me. Management are out beating their drum pleading …